Avelumab (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Avelumab" in Spanish language version.

refsWebsite

Global rank Spanish rank

1^st place

447^th place

668^th place

68^th place

91^st place

4^th place

2^nd place

low place

low place

399^th place

648^th place

biopharmadive.com

«Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial». Journal for Immunotherapy of Cancer 6 (1): 7. January 2018. PMC 5774167. PMID 29347993. doi:10.1186/s40425-017-0310-x.
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A (July 2013). «Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma». The New England Journal of Medicine 369 (2): 134-44. PMC 4126516. PMID 23724846. doi:10.1056/NEJMoa1305133.

«Bavencio Monograph for Professionals». Drugs.com. American Society of Health-System Pharmacists, Inc. 27 de enero de 2020. Consultado el 2 de agosto de 2020.

«Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial». Journal for Immunotherapy of Cancer 6 (1): 7. January 2018. PMC 5774167. PMID 29347993. doi:10.1186/s40425-017-0310-x.
Hamid O, Robert C, Daud A, Hodi FS, Hwu WJ, Kefford R, Wolchok JD, Hersey P, Joseph RW, Weber JS, Dronca R, Gangadhar TC, Patnaik A, Zarour H, Joshua AM, Gergich K, Elassaiss-Schaap J, Algazi A, Mateus C, Boasberg P, Tumeh PC, Chmielowski B, Ebbinghaus SW, Li XN, Kang SP, Ribas A (July 2013). «Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma». The New England Journal of Medicine 369 (2): 134-44. PMC 4126516. PMID 23724846. doi:10.1056/NEJMoa1305133.

Merck-Pfizer Alliance. «Merck-Pfizer Alliance Avelumab Fact Sheet». Archivado desde el original el 17 de mayo de 2017. Consultado el 2 de diciembre de 2015.

Merck-Pfizer Alliance. «Merck-Pfizer Alliance Avelumab Fact Sheet». Archivado desde el original el 17 de mayo de 2017. Consultado el 2 de diciembre de 2015.
«Public summary of opinion on orphan designation: Avelumab for the treatment of gastric cancer». Agencia Europea de Medicamentos. 9 de enero de 2017. Archivado desde el original el 5 de agosto de 2017. Consultado el 5 de agosto de 2020.